CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- 144 Insider Sale of Securities
- 4 Planned sale EXECUTIVE CHAIRMAN sold 50,000 shares at an average $327.97 ($16,398,267)
- 144 Insider Sale of Securities
- 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 18,160 shares at an average $325.88 ($5,917,907)
- 4 Planned sale CEO AND PRESIDENT sold 1,698 shares at $320.99 ($545,041)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale PRESIDENT, CHIEF BUS. OFFICER sold 6,517 shares at $321.53 ($2,095,411)
- 4 Planned sale Director sold 6,000 shares at $325.32 ($1,951,942)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale EXECUTIVE CHAIRMAN sold 2,000 shares at $320.90 ($641,800)
- 4 Planned sale Director sold 9,150 shares at an average $315.66 ($2,888,325)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 795 shares at an average $271.74 ($216,030)
- 4 Planned sale CEO AND PRESIDENT sold 3,076 shares at an average $266.39 ($819,431)
Page 4 of 94 · 1,862 filings